Resideo (REZI) Form 144 Filed for 3,333-Share Sale via Morgan Stanley

Rhea-AI Filing Summary

Resideo Technologies (REZI) filed a Form 144 notifying a proposed sale of 3,333 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $115,141.82 and an approximate sale date of 08/26/2025. The shares were acquired as restricted stock that vested on 11/18/2020 under a registered plan. The filing lists 148,763,403 shares outstanding for the issuer. The notice also discloses recent sales by the same person: 2,790 shares on 07/07/2025 for $65,983.08 and 2,789 shares on 08/12/2025 for $82,659.96. The filer represents there is no undisclosed material adverse information and the sale is being processed through a broker.

Positive

• Clear disclosure of the proposed sale including broker, share count, and aggregate market value
• Acquisition history provided (restricted stock vesting date shown), supporting transparency
• Recent prior sales disclosed for the past three months, aligning with Form 144 requirements
• Filer attestation that no undisclosed material adverse information is known

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale; size is immaterial relative to outstanding shares and appears compliant with Form 144 requirements.

The notice documents a proposed sale of 3,333 common shares via a registered broker, indicating the securities were issued as restricted stock that vested in November 2020. Recent disposals by the same person in July and August 2025 are disclosed, supporting transparency. Given the reported outstanding share count, the transaction size is small and unlikely to materially affect market supply or valuation. The filing includes the required attestation regarding undisclosed material information.

Compliance/Risk Analyst

TL;DR: Disclosure meets procedural requirements; monitoring of insider trading patterns is advised but no immediate compliance red flags.

The Form 144 names a broker and provides acquisition details (restricted stock vesting) and prior sales in the past three months, which are necessary elements for regulatory compliance. The signature attestation about absence of undisclosed material adverse information is present. From a compliance perspective, the filing appears complete; ongoing review of any trading plan dates or 10b5-1 instructions (if adopted) would be standard practice, though none are specified in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3333	115141.82	148763403	08/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/18/2020	Restricted stock vesting under a registered plan	Issuer			3333	11/18/2020	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Nina Richardson 16100 N. 71st Street, Suite 550, Scottsdale AZ 85254	Common	08/12/2025	2789	82659.96
Nina Richardson 16100 N. 71st Street, Suite 550, Scottsdale AZ 85254	Common	07/07/2025	2790	65983.08

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the REZI Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 3,333 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $115,141.82 and an approximate sale date of 08/26/2025.

How were the shares being sold by the REZI filer acquired?

The shares were acquired as restricted stock that vested on 11/18/2020 under a registered plan, per the filing.

Has the filer sold other REZI shares recently?

Yes; the filing reports sales of 2,790 shares on 07/07/2025 for $65,983.08 and 2,789 shares on 08/12/2025 for $82,659.96.

Who is the broker handling the proposed sale in the REZI filing?

The broker named in the Form 144 is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the filing state whether there is undisclosed material information about REZI?

The filer represents by signing the notice that they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.

What is the issuer's reported number of outstanding shares in the filing?

The Form 144 reports 148,763,403 shares outstanding for the issuer.